Skip to main content

Table 2 Results of antibiotic susceptibility of the clinical P. aeruginosa isolate, CCASUP2 against the tested antimicrobial agents

From: In vivo evaluation of a recombinant N-acylhomoserine lactonase formulated in a hydrogel using a murine model infected with MDR Pseudomonas aeruginosa clinical isolate, CCASUP2

Antimicrobial agent

Susceptibility to antimicrobial agent

MIC (μg/ml)

Co-amoxiclav (AMC)

R

512

Azithromycin (AZM)

R

32

Cefotaxime (CTX)

R

64

Ciprofloxacin (CIP)

R

128

gentamicin (CN)

R

64

Meropenem (MEM)

S

2

Levofloxacin (LEV)

R

32

Tobramycin (TOB)

R

16

Aztreonam (ATM)

R

16

  1. S Sensitive, I Intermediate resistance, R  resistant)